Issn Print: 0190-9622
Publication Date: 2017/08/01
Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)
Andrew Blauvelt; Kim A. Papp; Mark G. Lebwohl; Lawrence J. Green; Sylvia Hsu; Varsha Bhatt; Shipra Rastogi; Radhakrishnan Pillai; Robert Israel
Author Information: Oregon Medical Research Center, Portland, Oregon
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.